CPHI & PMEC China 2026
06/2026 – 06/2026
Über das Unternehmen
- Firmenname (rechtlich): ZHEJIANG JINGXIN PHARMACEUTICAL CO.LTD.
- Registrierungsland: China
- Adresse: No.800, Dadao East Road,Chengguan, Zhejiang
- Gründungsjahr: 1990
Beschreibung:
Jingxin Pharm is a producer of APIs such as Simvastatin, Levofloxacin Hemihydrate, Ciprofloxacin HCl, Gatifloxacin, and Enrofloxacin Base and HCl, as well as finished dosage forms such as tablets, capsules and injections. Jingxin Pharm holds EDMF and US DMF filings for all products, and its formulation factory has received German GMP approval.
Geschäftsaktivitäten
Fertigarzneiformen
Hersteller
Hilfsstoffe & Zusatzstoffe
Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Northern Europe: Denmark, Estonia, Finland, Iceland
Unsere Produkte & Dienstleistungen
Proofs
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen